Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study
- PMID: 29450186
- PMCID: PMC5801449
- DOI: 10.1016/j.ijchv.2014.06.008
Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study
Erratum in
-
Corrigendum to "Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study" [Int. J. Cardiol. Heart Vessels (2014) 90-96].Int J Cardiol Heart Vasc. 2016 Jul 20;12:95. doi: 10.1016/j.ijcha.2016.07.002. eCollection 2016 Sep. Int J Cardiol Heart Vasc. 2016. PMID: 31265719 Free PMC article.
Abstract
Background: The PANORAMA study was designed to collect concurrent data on subjects from different worldwide regions implanted with CRM devices.
Methods: In this prospective, multi-center study, we analyzed baseline data on 8586 subjects implanted with CRM devices with no additional selection criteria (66% pacemaker (IPG), 16% implantable cardiac defibrillators (ICD), 17% cardiac resynchronization therapy (CRT) and < 1% Internal Loop Recorder) from 156 hospitals across 6 geographical regions between 2005 and 2011.
Results: Regardless of the device implanted, subjects from the Middle East and India often had more diabetes than other regions. Eastern and Western Europe had higher rates of atrial fibrillation reported, and men were more likely to smoke than women (46% vs 11%, p < 0.001). Within the CRT cohort there was significant variation in the proportion of males receiving a device, ranging from 55% in India to 83% in Eastern Europe.
Conclusions: We provide comprehensive descriptive data on patients receiving CRM devices from a range of geographies that are not typically reported in literature. We found significant variations in clinical characteristics and implant practices. Long term follow-up data will help evaluate if these variations require adjustments to outcome expectations.
Keywords: AV, atrio-ventricular; Bradyarrhythmias; CRM, cardiac rhythm management; CRT, cardiac resynchronization therapy; Cardiac pacing; Cardiac resynchronization; DFT, defibrillation threshold testing; Defibrillators; Heart failure; ICD, implantable cardioverter-defibrillator; IPG, implantable pulse generator; Tachyarrhythmias.
Similar articles
-
Real-world geographic variations in the use of cardiac implantable electronic devices-The PANORAMA 2 observational cohort study.Pacing Clin Electrophysiol. 2018 Jun 13. doi: 10.1111/pace.13410. Online ahead of print. Pacing Clin Electrophysiol. 2018. PMID: 29897627
-
The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.J Cardiovasc Electrophysiol. 2021 Aug;32(8):2285-2294. doi: 10.1111/jce.15149. Epub 2021 Jul 9. J Cardiovasc Electrophysiol. 2021. PMID: 34216069
-
Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.JAMA Netw Open. 2021 Jan 4;4(1):e2035470. doi: 10.1001/jamanetworkopen.2020.35470. JAMA Netw Open. 2021. PMID: 33496796 Free PMC article.
-
Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.Evid Rep Technol Assess (Full Rep). 2007 Jun;(152):1-199. Evid Rep Technol Assess (Full Rep). 2007. PMID: 17764218 Free PMC article. Review.
-
Defibrillators: Selecting the Right Device for the Right Patient.Circulation. 2016 Nov 1;134(18):1390-1404. doi: 10.1161/CIRCULATIONAHA.116.021889. Circulation. 2016. PMID: 27799257 Review.
Cited by
-
A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.Indian Heart J. 2016 Jan-Feb;68(1):68-71. doi: 10.1016/j.ihj.2015.06.037. Epub 2016 Jan 18. Indian Heart J. 2016. PMID: 26896270 Free PMC article.
-
The Average Age of Atrioventricular Block Onset in Middle Eastern Patients with Cardiac Rhythm Devices Adjusted for the Overall Young Population: Insights from a Multicenter International Registry.Glob Heart. 2024 Apr 25;19(1):40. doi: 10.5334/gh.1321. eCollection 2024. Glob Heart. 2024. PMID: 38681972 Free PMC article.
-
Global differences in acute heart failure treatment: analysis of the STRONG-HF site feasibility questionnaire.ESC Heart Fail. 2023 Aug;10(4):2236-2247. doi: 10.1002/ehf2.14370. Epub 2023 Apr 19. ESC Heart Fail. 2023. PMID: 37076782 Free PMC article.
References
-
- Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237. - PubMed
-
- Young J.B., Abraham W.T., Smith A.L., Leon A.R., Lieberman R., Wilkoff B. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 2003;289(20):2685–2694. - PubMed
-
- Linde C., Abraham W.T., Gold M.R., Sutton St John M., Ghio S., Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–1843. - PubMed
-
- Moss A.J., Hall W.J., Cannom D.S., Klein H., Brown M.W., Daubert J.P. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–1338. - PubMed
-
- Tang A.S., Wells G.A., Talajic M., Arnold M.O., Sheldon R., Connolly S. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385–2395. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials